Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
may have aminotransferase activity. Additionally we are shipping and and many more products for this protein.
Showing 10 out of 62 products:
Human Polyclonal GFPT2 Primary Antibody for IHC, IHC (p) - ABIN4891037
Guillaumond, Leca, Olivares, Lavaut, Vidal, Berthezène, Dusetti, Loncle, Calvo, Turrini, Iovanna, Tomasini, Vasseur: Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. in Proceedings of the National Academy of Sciences of the United States of America 2013
mouse glutamine-fructose-6-phosphate amidotransferase 2 (GFAT2) is phosphorylated by cAMP-dependent protein kinase, which increases the enzyme activity
GNPDA1 (show GNPDA1 Antibodies) siRNA induced GFAT2 which was hardly measurable in these cells under standard culture conditions, GNPDA2 (show GNPDA2 Antibodies) siRNA increased GFAT1 (show GFPT1 Antibodies), and GFAT1 (show GFPT1 Antibodies) siRNA increased the expression of hyaluronan synthase 2 (HAS2 (show HAS2 Antibodies)). Silencing of GFAT1 (show GFPT1 Antibodies) stimulated GNPDA1 (show GNPDA1 Antibodies) and GDPDA2, and inhibited cell migration.
association of nine single nucleotide polymorphisms in ADPRT1 (show PARP1 Antibodies), AKR1B1 (show AKR1B1 Antibodies)), RAGE (show AGER Antibodies), GFPT2 and PAI-1 (show SERPINE1 Antibodies) genes with chronic renal insufficiency among Asian Indians with type 2 diabetes
GFPT2 mRNA levels in transformed lymphocytes significantly increased among African-Americans. Associated allele of 3' UTR (show UTS2R Antibodies) SNP approximately 2-fold overexpressed. 3' UTR (show UTS2R Antibodies) variant results in increased GFPT2 mRNA with resultant increased hexosamine flux.
Increased GFAT (show GFPT1 Antibodies) activity appears to be associated with insulin (show INS Antibodies) resistance, postprandial hyperglycaemia and oxidative stress in T2DM and may point towards a potential pathway amenable for therapeutic intervention.
may have aminotransferase activity
glutamine fructose-6-phosphate transaminase 1
, glutamine-fructose-6-phosphate transaminase 2
, glutamine-fructose-6-phosphate transaminase 1
, glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2
, glutamine fructose-6-phosphate transaminase 2
, D-fructose-6-phosphate amidotransferase 2
, GFAT 2
, glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2
, glutamine:fructose 6 phosphate amidotransferase 2
, glutamine:fructose-6-phosphate amidotransferase 2
, hexosephosphate aminotransferase 2
, glutamine: fructose-6-phosphate aminotransferase 2